Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1994-01-18
1995-09-19
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A61K 3159
Patent
active
054515742
ABSTRACT:
Compounds of the formula ##STR1## wherein R is hydrogen, hydroxy, or fluorine, and X is H.sub.2 are useful as agents for the treatment of hyperproliferative disorders of the skin such as psoriasis, as agents for the treatment of cancer, such as, leukemia, and as agents for the treatment of sebaceous gland diseases, such as, acne and seborrheic dermatitis.
REFERENCES:
patent: 4613594 (1986-09-01), Baggiolini et al.
patent: 4804502 (1989-02-01), Baggiolini et al.
patent: 5087619 (1992-02-01), Baggiolini et al.
patent: 5281731 (1994-01-01), DeLuca et al.
Farach-Carson, et al. Endocrinology vol. 129(4), pp. 1876-1884 (1991).
Pinder, et al. Journal of Pharm. Sci , vol. 56(8), pp. 970-973 (1967).
The Society for Investigative Dermatology p. 709-714 (1986).
In Vitro Models for Cancer Research III, 246-274 (1986).
Blood 78, 75-82 (1991).
Baggiolini Barbara J.
Baggiolini, deceased Enrico G.
Shiuey Shian-Jan
Uskokovic Milan R.
Ciambrone Coletti Ellen
Gould George M.
Hoffman-La Roche Inc.
Johnston George W.
Kestler Kimberly J.
LandOfFree
Vitamin D3 Flourinated Analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D3 Flourinated Analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D3 Flourinated Analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1828241